1. Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations
   M. N. Abbas et al, 2020, Clinical and Translational Oncology CrossRef
2. Anemone medicinal plants: ethnopharmacology, phytochemistry and biology
   Da-Cheng Hao et al, 2017, Acta Pharmaceutica Sinica B CrossRef
3. CN‐3 increases TMZ sensitivity and induces ROS‐dependent apoptosis and autophagy in TMZ‐resistance glioblastoma
   Yu‐Ye Xue et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
4. Natural products: a hope for glioblastoma patients
   Raghupathy Vengoji et al, 2018, Oncotarget CrossRef
5. Medicinal Plants for Glioblastoma Treatment
   Shreeja Datta et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
6. The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
   Fei Shi et al, 2018, Oncotarget CrossRef
7. Biodiversity, Chemodiversity, and Pharmacotherapy of Anemone Medicinal Plants
   Da-Cheng Hao, 2019, Ranunculales Medicinal Plants CrossRef
8. Reduction of SCUBE3 by a new marine-derived asterosaponin leads to arrest of glioma cells in G1/S
   Peng-Cheng Qiu et al, 2020, Oncogenesis CrossRef
9. LC/MS Analysis of Saponin Fraction from the Leaves of Elaeagnus rhamnoides (L.) A. Nelson and Its Biological Properties in Different In Vitro Models
   Jerzy Żuchowski et al, 2020, Molecules CrossRef
10. Multidirectional effects of saponin fraction isolated from the leaves of sea buckthorn Elaeagnus rhamnoides (L.) A. Nelson
    Michał Juszczak et al, 2021, Biomedicine & Pharmacotherapy CrossRef